Home › Trial NCT01529684
A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body
- Trial IDNCT01529684
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAstellas Pharma Global Development, Inc.
- Enrollment5
- Start date2012-03-19
- ConditionsAdvanced Solid Tumors · Pharmacokinetics of 14C-OSI-906
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.